1,3-Dihydro-2H-imidazo[4,5-b]pyrazin-2-one

Introduction

CAS No. :	16328-63-5	MDL No. :	MFCD08669462
Formula :	C5H4N4O	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	CGKLYWOFLUIKCX-UHFFFAOYSA-N
M.W :	136.11	Pubchem ID :	279243
Synonyms :

Physicochemical Properties

Num. heavy atoms :	10
Num. arom. heavy atoms :	9
Fraction Csp3 :	0.0
Num. rotatable bonds :	0
Num. H-bond acceptors :	3.0
Num. H-bond donors :	2.0
Molar Refractivity :	34.51
TPSA :	74.43 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	No
P-gp substrate :	No
CYP1A2 inhibitor :	No
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-7.78 cm/s

Lipophilicity

Log Po/w (iLOGP) :	0.59
Log Po/w (XLOGP3) :	-0.91
Log Po/w (WLOGP) :	-0.35
Log Po/w (MLOGP) :	-1.17
Log Po/w (SILICOS-IT) :	1.33
Consensus Log Po/w :	-0.1

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	1.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-0.78
Solubility :	22.8 mg/ml ; 0.167 mol/l
Class :	Very soluble
Log S (Ali) :	-0.17
Solubility :	92.0 mg/ml ; 0.676 mol/l
Class :	Very soluble
Log S (SILICOS-IT) :	-2.04
Solubility :	1.24 mg/ml ; 0.00908 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	1.68

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P280-P301+P312-P302+P352-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine